ONL logo.jpg
ONL Therapeutics to Present at the XXVth Biennial Meeting of the International Society for Eye Research
February 13, 2023 07:00 ET | ONL Therapeutics
ANN ARBOR, Mich., Feb. 13, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
ONL logo.jpg
ONL Therapeutics to Present at 2023 BIO CEO & Investor Conference
February 02, 2023 07:00 ET | ONL Therapeutics
ANN ARBOR, Mich., Feb. 02, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
ONL logo.jpg
ONL Therapeutics Receives U.S. FDA Clearance of Investigational New Drug Application for ONL1204 Ophthalmic Solution
February 01, 2023 07:00 ET | ONL Therapeutics
ANN ARBOR, Mich., Feb. 01, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
Lumotive M30 Lidar Reference Design
Lumotive and Lumentum Introduce Innovative Reference Design to Enable Faster Adoption of Next-Generation 3D LiDAR Solutions
January 30, 2023 10:00 ET | Lumotive
SEATTLE and SAN JOSE, Calif., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Lumotive, the developer of Light Control Metasurface (LCM™) beam steering chips enabling the next generation of 3D sensors, and Lumentum...
ONL logo.jpg
ONL Therapeutics to Highlight New Data in Upcoming Scientific Presentations at the 46th Annual Macula Society Meeting and the XXVth Biennial Meeting of the International Society for Eye Research
January 26, 2023 07:00 ET | ONL Therapeutics
ANN ARBOR, Mich., Jan. 26, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
Jim McGrann
Percept Corporation Names Vision Industry Leader Jim McGrann as President and Chief Operating Officer
January 16, 2023 07:30 ET | Percept
LAS VEGAS, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Percept Corporation, a developer of eye tracking, eye control, and perceptual optimization technology for the global vision industry, is pleased to...
RG logo 7.png
RetinalGeniX Technologies, Inc. to Present at the Emerging Growth Conference Wednesday, October 26, 2022
October 24, 2022 13:05 ET | RetinalGeniX Technologies, Inc.
PETALUMA, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) -- RetinalGeniX Technologies, Inc. OTCQB: RTGN to Present at the Emerging Growth Conference. RetinalGeniX Technologies, Inc. (RTGN) is pleased to...
Orange County Vision Center Announces Grand Opening of New Location
October 11, 2022 09:22 ET | Orange County Vision Center
GARDEN GROVE, Calif., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Orange County Vision Center is excited to announce the grand opening of a new location in Garden Grove, CA! The new office is spacious and...
Vision Care Market Size Worth USD 237 Billion by 2030 at 4.03% CAGR - Report by Market Research Future (MRFR)
August 11, 2022 04:30 ET | Market Research Future
New York, USA, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Vision Care Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Vision Care Market Information By...
Vinay Mehindru picture
Vinay Mehindru, MD, MBA Appointed to RetinalGenix Technologies Inc. Board of Directors
July 26, 2022 06:15 ET | RetinalGeniX Technologies, Inc.
PETALUMA, Calif., July 26, 2022 (GLOBE NEWSWIRE) -- RetinalGenix™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGenix” or the “Company”), announced today the appointment of Vinay Mehindru, MD, MBA to the...